In cancer cells with impaired DNA repair machinery, such as those harboring BAP1 loss or TP53 mutations—common features in PM—CHK1 activity supports survival under genotoxic stress, making it a promising therapeutic target. The gene discussed is BAP1; the disease is cancer.